Pure Global AI
CDSCO UID MFG/IVD/2021/000021_f357a2b906c1decfba73e6d73a0113fc_9e6efb054b889567602731bd8b1b36fd

Quantitative Turbidimetric Immunoassay for Fibrinogen

TULIP DIAGNOSTICS PRIVATE LIMITEDDevice Class Class CIndia CDSCOBrand: Monospecific Coombs Serum
VerifiedCDSCO · official registry
Registration details
UID
MFG/IVD/2021/000021_f357a2b906c1decfba73e6d73a0113fc_9e6efb054b889567602731bd8b1b36fd
Device class
Class C
Brand name
Monospecific Coombs Serum
Approving authority
Sub Zonal Goa
Product information
Quantia Fibrinogen is used in evaluating patients with a risk of atherosclerotic disease due to high fibrinogen levels. Low fibrinogen levels are observed in patients with liver disease, disseminated intravascular coagulation (Monospecific Coombs Serum)
About this record

Quantitative Turbidimetric Immunoassay for Fibrinogen is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_f357a2b906c1decfba73e6d73a0113fc_9e6efb054b889567602731bd8b1b36fd. This device is marketed under the brand name Monospecific Coombs Serum. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Sub Zonal Goa.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.